Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Daily News

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Caitlin E. Cox

August 18, 2020

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Caitlin E. Cox

October 03, 2014

Advertisement

Donor Hearts Fare Better With Novel Method After Circulatory Death

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Safe to Upgrade From Pacemaker or Defibrillator to CRT

ECMO in AMICS: Amid Few Prospective Trials, a Multicenter Registry Yields Insights

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

TCTMD’s Top 10 Most Popular Stories for June 2017

IABP Therapy May Benefit Patients With Large STEMI, Persistent Ischemia Post-PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content